Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) Stock Competitors & Peer Comparison
See JAGLX's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Asset Management - Global Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for JAGLX and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| JAGLX | $90.74 | +0.07% | 6.1B | N/A | N/A | N/A |
| VTI | $379.73 | -0.32% | 2.3T | 27.05 | $14.04 | +1.03% |
| IVV | $773.92 | +0.66% | 900.2B | 27.95 | $27.80 | +1.06% |
| VXUS | $88.41 | +0.50% | 679.5B | 18.55 | $4.77 | +2.48% |
| VWO | $61.44 | +0.74% | 171.6B | 17.35 | $3.54 | +2.25% |
| IEMG | $83.65 | +1.65% | 171.2B | 18.13 | $4.61 | +2.16% |
| SPYM | $90.67 | -0.38% | 160.1B | 27.58 | $3.29 | +1.00% |
| IWF | $123.41 | +1.31% | 134.5B | 32.34 | $3.82 | +0.35% |
| VT | $161.73 | -0.02% | 100.4B | 23.09 | $7.00 | +1.54% |
| RSP | $219.00 | -0.48% | 98.5B | 23.69 | $9.24 | +1.46% |
Stock Comparison
Vanguard Morningstar Total Stock Market ETF (AMEX: VTI)
JAGLX vs VTI Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, VTI has a market cap of 2.3T. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while VTI trades at $379.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas VTI's P/E ratio is 27.05. In terms of profitability, JAGLX's ROE is N/A, compared to VTI's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to VTI. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check VTI's competition here
iShares Core S&P 500 ETF (AMEX: IVV)
JAGLX vs IVV Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, IVV has a market cap of 900.2B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while IVV trades at $773.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas IVV's P/E ratio is 27.95. In terms of profitability, JAGLX's ROE is N/A, compared to IVV's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to IVV. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check IVV's competition here
Vanguard Total International Stock ETF (NASDAQ: VXUS)
JAGLX vs VXUS Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, VXUS has a market cap of 679.5B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while VXUS trades at $88.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas VXUS's P/E ratio is 18.55. In terms of profitability, JAGLX's ROE is N/A, compared to VXUS's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to VXUS. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check VXUS's competition here
Vanguard FTSE Emerging Markets ETF (AMEX: VWO)
JAGLX vs VWO Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, VWO has a market cap of 171.6B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while VWO trades at $61.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas VWO's P/E ratio is 17.35. In terms of profitability, JAGLX's ROE is N/A, compared to VWO's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to VWO. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check VWO's competition here
iShares Core MSCI Emerging Markets ETF (AMEX: IEMG)
JAGLX vs IEMG Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, IEMG has a market cap of 171.2B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while IEMG trades at $83.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas IEMG's P/E ratio is 18.13. In terms of profitability, JAGLX's ROE is N/A, compared to IEMG's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to IEMG. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check IEMG's competition here
State Street SPDR Portfolio S&P 500 ETF (AMEX: SPYM)
JAGLX vs SPYM Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, SPYM has a market cap of 160.1B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while SPYM trades at $90.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas SPYM's P/E ratio is 27.58. In terms of profitability, JAGLX's ROE is N/A, compared to SPYM's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to SPYM. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check SPYM's competition here
iShares Russell 1000 Growth ETF (AMEX: IWF)
JAGLX vs IWF Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, IWF has a market cap of 134.5B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while IWF trades at $123.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas IWF's P/E ratio is 32.34. In terms of profitability, JAGLX's ROE is N/A, compared to IWF's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to IWF. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check IWF's competition here
Vanguard Total World Stock ETF (AMEX: VT)
JAGLX vs VT Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, VT has a market cap of 100.4B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while VT trades at $161.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas VT's P/E ratio is 23.09. In terms of profitability, JAGLX's ROE is N/A, compared to VT's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to VT. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check VT's competition here
Invesco S&P 500 Equal Weight ETF (AMEX: RSP)
JAGLX vs RSP Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, RSP has a market cap of 98.5B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while RSP trades at $219.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas RSP's P/E ratio is 23.69. In terms of profitability, JAGLX's ROE is N/A, compared to RSP's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to RSP. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check RSP's competition here
Vanguard FTSE All-World ex-US ETF (AMEX: VEU)
JAGLX vs VEU Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, VEU has a market cap of 98.4B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while VEU trades at $86.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas VEU's P/E ratio is 18.67. In terms of profitability, JAGLX's ROE is N/A, compared to VEU's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to VEU. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check VEU's competition here
iShares Russell 1000 Value ETF (AMEX: IWD)
JAGLX vs IWD Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, IWD has a market cap of 81.3B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while IWD trades at $257.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas IWD's P/E ratio is 24.14. In terms of profitability, JAGLX's ROE is N/A, compared to IWD's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to IWD. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check IWD's competition here
iShares MSCI EAFE ETF (AMEX: EFA)
JAGLX vs EFA Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, EFA has a market cap of 78.9B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while EFA trades at $108.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas EFA's P/E ratio is 19.25. In terms of profitability, JAGLX's ROE is N/A, compared to EFA's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to EFA. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check EFA's competition here
iShares S&P 500 Growth ETF (AMEX: IVW)
JAGLX vs IVW Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, IVW has a market cap of 76.8B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while IVW trades at $140.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas IVW's P/E ratio is 781.86. In terms of profitability, JAGLX's ROE is N/A, compared to IVW's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to IVW. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check IVW's competition here
First Eagle Global Fund (NASDAQ: SGENX)
JAGLX vs SGENX Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, SGENX has a market cap of 75.7B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while SGENX trades at $90.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas SGENX's P/E ratio is 19.04. In terms of profitability, JAGLX's ROE is N/A, compared to SGENX's ROE of N/A. Regarding short-term risk, JAGLX is more volatile compared to SGENX. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check SGENX's competition here
Schwab International Equity ETF (AMEX: SCHF)
JAGLX vs SCHF Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, SCHF has a market cap of 68.5B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while SCHF trades at $28.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas SCHF's P/E ratio is 19.29. In terms of profitability, JAGLX's ROE is N/A, compared to SCHF's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to SCHF. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check SCHF's competition here
iShares Core MSCI Total International Stock ETF (NASDAQ: IXUS)
JAGLX vs IXUS Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, IXUS has a market cap of 60.4B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while IXUS trades at $98.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas IXUS's P/E ratio is 18.60. In terms of profitability, JAGLX's ROE is N/A, compared to IXUS's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to IXUS. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check IXUS's competition here
iShares Russell Mid-Cap ETF (AMEX: IWR)
JAGLX vs IWR Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, IWR has a market cap of 57.5B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while IWR trades at $111.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas IWR's P/E ratio is 23.72. In terms of profitability, JAGLX's ROE is N/A, compared to IWR's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to IWR. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check IWR's competition here
Vanguard Russell 1000 Growth ETF (NASDAQ: VONG)
JAGLX vs VONG Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, VONG has a market cap of 55.7B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while VONG trades at $127.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas VONG's P/E ratio is 32.29. In terms of profitability, JAGLX's ROE is N/A, compared to VONG's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to VONG. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check VONG's competition here
iShares S&P 500 Value ETF (AMEX: IVE)
JAGLX vs IVE Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, IVE has a market cap of 50.4B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while IVE trades at $236.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas IVE's P/E ratio is 24.72. In terms of profitability, JAGLX's ROE is N/A, compared to IVE's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to IVE. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check IVE's competition here
iShares Russell 1000 ETF (AMEX: IWB)
JAGLX vs IWB Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, IWB has a market cap of 49.3B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while IWB trades at $421.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas IWB's P/E ratio is 27.53. In terms of profitability, JAGLX's ROE is N/A, compared to IWB's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to IWB. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check IWB's competition here
State Street SPDR Portfolio Developed World ex-US ETF (AMEX: SPDW)
JAGLX vs SPDW Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, SPDW has a market cap of 41.9B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while SPDW trades at $52.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas SPDW's P/E ratio is 19.07. In terms of profitability, JAGLX's ROE is N/A, compared to SPDW's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to SPDW. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check SPDW's competition here
Vanguard FTSE Europe ETF (AMEX: VGK)
JAGLX vs VGK Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, VGK has a market cap of 38.3B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while VGK trades at $91.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas VGK's P/E ratio is 18.47. In terms of profitability, JAGLX's ROE is N/A, compared to VGK's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to VGK. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check VGK's competition here
State Street SPDR Portfolio S&P 500 Value ETF (AMEX: SPYV)
JAGLX vs SPYV Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, SPYV has a market cap of 37B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while SPYV trades at $63.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas SPYV's P/E ratio is 23.85. In terms of profitability, JAGLX's ROE is N/A, compared to SPYV's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to SPYV. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check SPYV's competition here
American Funds Global Balanced Fd Cl F-1 (NASDAQ: GBLEX)
JAGLX vs GBLEX Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, GBLEX has a market cap of 33.2B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while GBLEX trades at $43.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas GBLEX's P/E ratio is 22.07. In terms of profitability, JAGLX's ROE is N/A, compared to GBLEX's ROE of N/A. Regarding short-term risk, JAGLX is more volatile compared to GBLEX. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check GBLEX's competition here
iShares MSCI Emerging Markets ETF (AMEX: EEM)
JAGLX vs EEM Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, EEM has a market cap of 32.2B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while EEM trades at $68.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas EEM's P/E ratio is 18.20. In terms of profitability, JAGLX's ROE is N/A, compared to EEM's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to EEM. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check EEM's competition here
Avantis Emerging Markets Equity ETF (AMEX: AVEM)
JAGLX vs AVEM Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, AVEM has a market cap of 28.3B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while AVEM trades at $96.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas AVEM's P/E ratio is 15.77. In terms of profitability, JAGLX's ROE is N/A, compared to AVEM's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to AVEM. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check AVEM's competition here
State Street SPDR S&P MIDCAP 400 ETF Trust (AMEX: MDY)
JAGLX vs MDY Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, MDY has a market cap of 28.3B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while MDY trades at $691.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas MDY's P/E ratio is 22.11. In terms of profitability, JAGLX's ROE is N/A, compared to MDY's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to MDY. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check MDY's competition here
iShares MSCI Emerging Markets ex China ETF (NASDAQ: EMXC)
JAGLX vs EMXC Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, EMXC has a market cap of 28.2B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while EMXC trades at $101.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas EMXC's P/E ratio is 20.18. In terms of profitability, JAGLX's ROE is N/A, compared to EMXC's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to EMXC. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check EMXC's competition here
Vanguard S&P 500 Growth ETF (AMEX: VOOG)
JAGLX vs VOOG Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, VOOG has a market cap of 27.4B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while VOOG trades at $84.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas VOOG's P/E ratio is 31.64. In terms of profitability, JAGLX's ROE is N/A, compared to VOOG's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to VOOG. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check VOOG's competition here
Schwab Fundamental International Large Company Index ETF (AMEX: FNDF)
JAGLX vs FNDF Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, FNDF has a market cap of 24.9B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while FNDF trades at $56.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas FNDF's P/E ratio is 17.75. In terms of profitability, JAGLX's ROE is N/A, compared to FNDF's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to FNDF. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check FNDF's competition here
iShares MSCI Japan ETF (AMEX: EWJ)
JAGLX vs EWJ Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, EWJ has a market cap of 23.2B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while EWJ trades at $98.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas EWJ's P/E ratio is 20.20. In terms of profitability, JAGLX's ROE is N/A, compared to EWJ's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to EWJ. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check EWJ's competition here
Vanguard Russell 1000 Value ETF (NASDAQ: VONV)
JAGLX vs VONV Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, VONV has a market cap of 22B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while VONV trades at $113.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas VONV's P/E ratio is 23.73. In terms of profitability, JAGLX's ROE is N/A, compared to VONV's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to VONV. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check VONV's competition here
American Funds Global Insight Fund Class F-1 (NASDAQ: AGVEX)
JAGLX vs AGVEX Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, AGVEX has a market cap of 21.3B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while AGVEX trades at $31.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas AGVEX's P/E ratio is 27.75. In terms of profitability, JAGLX's ROE is N/A, compared to AGVEX's ROE of N/A. Regarding short-term risk, JAGLX is more volatile compared to AGVEX. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check AGVEX's competition here
Avantis International Small Cap Value ETF (AMEX: AVDV)
JAGLX vs AVDV Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, AVDV has a market cap of 20.6B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while AVDV trades at $113.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas AVDV's P/E ratio is 14.48. In terms of profitability, JAGLX's ROE is N/A, compared to AVDV's ROE of +0.00%. Regarding short-term risk, JAGLX is similarly volatile compared to AVDV. This indicates similar risk in terms of short-term price fluctuations for JAGLX.Check AVDV's competition here
Dimensional - International Value ETF (AMEX: DFIV)
JAGLX vs DFIV Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, DFIV has a market cap of 20.5B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while DFIV trades at $58.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas DFIV's P/E ratio is 16.03. In terms of profitability, JAGLX's ROE is N/A, compared to DFIV's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to DFIV. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check DFIV's competition here
Invesco S&P 500 Quality ETF (AMEX: SPHQ)
JAGLX vs SPHQ Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, SPHQ has a market cap of 20.4B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while SPHQ trades at $85.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas SPHQ's P/E ratio is 27.78. In terms of profitability, JAGLX's ROE is N/A, compared to SPHQ's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to SPHQ. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check SPHQ's competition here
iShares Russell Mid-Cap Growth ETF (AMEX: IWP)
JAGLX vs IWP Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, IWP has a market cap of 20.1B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while IWP trades at $139.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas IWP's P/E ratio is 31.28. In terms of profitability, JAGLX's ROE is N/A, compared to IWP's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to IWP. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check IWP's competition here
iShares Russell 3000 ETF (AMEX: IWV)
JAGLX vs IWV Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, IWV has a market cap of 19.9B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while IWV trades at $438.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas IWV's P/E ratio is 27.21. In terms of profitability, JAGLX's ROE is N/A, compared to IWV's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to IWV. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check IWV's competition here
State Street SPDR Portfolio Emerging Markets ETF (AMEX: SPEM)
JAGLX vs SPEM Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, SPEM has a market cap of 18.1B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while SPEM trades at $53.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas SPEM's P/E ratio is 17.13. In terms of profitability, JAGLX's ROE is N/A, compared to SPEM's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to SPEM. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check SPEM's competition here
iShares ESG Aware MSCI USA ETF (NASDAQ: ESGU)
JAGLX vs ESGU Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, ESGU has a market cap of 18B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while ESGU trades at $168.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas ESGU's P/E ratio is 27.83. In terms of profitability, JAGLX's ROE is N/A, compared to ESGU's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to ESGU. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check ESGU's competition here
Fidelity MSCI Information Technology Index ETF (AMEX: FTEC)
JAGLX vs FTEC Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, FTEC has a market cap of 17.5B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while FTEC trades at $289.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas FTEC's P/E ratio is 34.18. In terms of profitability, JAGLX's ROE is N/A, compared to FTEC's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to FTEC. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check FTEC's competition here
Dimensional - International Core Equity Market ETF (AMEX: DFAI)
JAGLX vs DFAI Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, DFAI has a market cap of 17.4B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while DFAI trades at $43.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas DFAI's P/E ratio is 18.92. In terms of profitability, JAGLX's ROE is N/A, compared to DFAI's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to DFAI. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check DFAI's competition here
iShares Russell Mid-Cap Value ETF (AMEX: IWS)
JAGLX vs IWS Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, IWS has a market cap of 15.9B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while IWS trades at $170.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas IWS's P/E ratio is 22.41. In terms of profitability, JAGLX's ROE is N/A, compared to IWS's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to IWS. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check IWS's competition here
Invesco S&P 500 Momentum ETF (AMEX: SPMO)
JAGLX vs SPMO Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, SPMO has a market cap of 15.5B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while SPMO trades at $149.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas SPMO's P/E ratio is 31.84. In terms of profitability, JAGLX's ROE is N/A, compared to SPMO's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to SPMO. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check SPMO's competition here
Vanguard FTSE Pacific ETF (AMEX: VPL)
JAGLX vs VPL Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, VPL has a market cap of 14.9B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while VPL trades at $118.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas VPL's P/E ratio is 19.19. In terms of profitability, JAGLX's ROE is N/A, compared to VPL's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to VPL. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check VPL's competition here
Vanguard FTSE All-World ex-US Small-Cap ETF (AMEX: VSS)
JAGLX vs VSS Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, VSS has a market cap of 14.8B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while VSS trades at $161.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas VSS's P/E ratio is 16.98. In terms of profitability, JAGLX's ROE is N/A, compared to VSS's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to VSS. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check VSS's competition here
iShares Russell 2000 Growth ETF (AMEX: IWO)
JAGLX vs IWO Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, IWO has a market cap of 14.5B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while IWO trades at $377.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas IWO's P/E ratio is 24.22. In terms of profitability, JAGLX's ROE is N/A, compared to IWO's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to IWO. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check IWO's competition here
iShares Russell 2000 Value ETF (AMEX: IWN)
JAGLX vs IWN Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, IWN has a market cap of 14.5B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while IWN trades at $224.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas IWN's P/E ratio is 16.74. In terms of profitability, JAGLX's ROE is N/A, compared to IWN's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to IWN. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check IWN's competition here
iShares MSCI South Korea ETF (AMEX: EWY)
JAGLX vs EWY Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, EWY has a market cap of 14.3B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while EWY trades at $188.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas EWY's P/E ratio is 107.93. In terms of profitability, JAGLX's ROE is N/A, compared to EWY's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to EWY. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check EWY's competition here
iShares MSCI Intl Quality Factor ETF (AMEX: IQLT)
JAGLX vs IQLT Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, IQLT has a market cap of 14B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while IQLT trades at $51.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas IQLT's P/E ratio is 20.41. In terms of profitability, JAGLX's ROE is N/A, compared to IQLT's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to IQLT. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check IQLT's competition here
iShares MSCI EAFE Small-Cap ETF (NASDAQ: SCZ)
JAGLX vs SCZ Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, SCZ has a market cap of 13.8B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while SCZ trades at $87.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas SCZ's P/E ratio is 16.23. In terms of profitability, JAGLX's ROE is N/A, compared to SCZ's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to SCZ. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check SCZ's competition here
Schwab Emerging Markets Equity ETF (AMEX: SCHE)
JAGLX vs SCHE Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, SCHE has a market cap of 13B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while SCHE trades at $37.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas SCHE's P/E ratio is 17.49. In terms of profitability, JAGLX's ROE is N/A, compared to SCHE's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to SCHE. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check SCHE's competition here
Capital Group Global Growth Equity ETF (AMEX: CGGO)
JAGLX vs CGGO Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, CGGO has a market cap of 12.2B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while CGGO trades at $40.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas CGGO's P/E ratio is 22.63. In terms of profitability, JAGLX's ROE is N/A, compared to CGGO's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to CGGO. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check CGGO's competition here
iShares MSCI ACWI ex U.S. ETF (NASDAQ: ACWX)
JAGLX vs ACWX Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, ACWX has a market cap of 12B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while ACWX trades at $78.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas ACWX's P/E ratio is 19.02. In terms of profitability, JAGLX's ROE is N/A, compared to ACWX's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to ACWX. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check ACWX's competition here
Lazard Global Listed Infrastructure Portfolio Open Shares (NASDAQ: GLFOX)
JAGLX vs GLFOX Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, GLFOX has a market cap of 12B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while GLFOX trades at $18.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas GLFOX's P/E ratio is 19.26. In terms of profitability, JAGLX's ROE is N/A, compared to GLFOX's ROE of N/A. Regarding short-term risk, JAGLX is more volatile compared to GLFOX. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check GLFOX's competition here
iShares ESG Aware MSCI EAFE ETF (NASDAQ: ESGD)
JAGLX vs ESGD Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, ESGD has a market cap of 12B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while ESGD trades at $107.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas ESGD's P/E ratio is 19.68. In terms of profitability, JAGLX's ROE is N/A, compared to ESGD's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to ESGD. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check ESGD's competition here
Lazard Global Listed Infrastructure Portfolio Institutional Shares (NASDAQ: GLIFX)
JAGLX vs GLIFX Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, GLIFX has a market cap of 12B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while GLIFX trades at $18.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas GLIFX's P/E ratio is 19.27. In terms of profitability, JAGLX's ROE is N/A, compared to GLIFX's ROE of N/A. Regarding short-term risk, JAGLX is more volatile compared to GLIFX. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check GLIFX's competition here
Vanguard Russell 1000 ETF (NASDAQ: VONE)
JAGLX vs VONE Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, VONE has a market cap of 11.8B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while VONE trades at $348.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas VONE's P/E ratio is 27.26. In terms of profitability, JAGLX's ROE is N/A, compared to VONE's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to VONE. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check VONE's competition here
First Trust NASDAQ Clean Edge Smart Grid Infrastructure Index Fund (NASDAQ: GRID)
JAGLX vs GRID Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, GRID has a market cap of 11.7B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while GRID trades at $178.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas GRID's P/E ratio is 29.72. In terms of profitability, JAGLX's ROE is N/A, compared to GRID's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to GRID. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check GRID's competition here
Janus Henderson Global Technology and Innovation Fund T Shares (NASDAQ: JAGTX)
JAGLX vs JAGTX Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, JAGTX has a market cap of 11.5B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while JAGTX trades at $85.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas JAGTX's P/E ratio is N/A. In terms of profitability, JAGLX's ROE is N/A, compared to JAGTX's ROE of N/A. Regarding short-term risk, JAGLX is less volatile compared to JAGTX. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check JAGTX's competition here
Janus Henderson Global Technology and Innovation Fund Class A (NASDAQ: JATAX)
JAGLX vs JATAX Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, JATAX has a market cap of 11.5B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while JATAX trades at $82.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas JATAX's P/E ratio is N/A. In terms of profitability, JAGLX's ROE is N/A, compared to JATAX's ROE of N/A. Regarding short-term risk, JAGLX is less volatile compared to JATAX. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check JATAX's competition here
Janus Henderson Global Technology and Innovation Fund Class C (NASDAQ: JAGCX)
JAGLX vs JAGCX Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, JAGCX has a market cap of 11.5B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while JAGCX trades at $64.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas JAGCX's P/E ratio is N/A. In terms of profitability, JAGLX's ROE is N/A, compared to JAGCX's ROE of N/A. Regarding short-term risk, JAGLX is less volatile compared to JAGCX. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check JAGCX's competition here
Janus Henderson Global Technology and Innovation Fund (NASDAQ: JATSX)
JAGLX vs JATSX Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, JATSX has a market cap of 11.4B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while JATSX trades at $78.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas JATSX's P/E ratio is N/A. In terms of profitability, JAGLX's ROE is N/A, compared to JATSX's ROE of N/A. Regarding short-term risk, JAGLX is less volatile compared to JATSX. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check JATSX's competition here
JPMorgan International Research Enhanced Equity ETF (AMEX: JIRE)
JAGLX vs JIRE Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, JIRE has a market cap of 11.4B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while JIRE trades at $85.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas JIRE's P/E ratio is 19.02. In terms of profitability, JAGLX's ROE is N/A, compared to JIRE's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to JIRE. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check JIRE's competition here
Global X - Artificial Intelligence & Technology ETF (NASDAQ: AIQ)
JAGLX vs AIQ Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, AIQ has a market cap of 11.2B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while AIQ trades at $64.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas AIQ's P/E ratio is 27.86. In terms of profitability, JAGLX's ROE is N/A, compared to AIQ's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to AIQ. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check AIQ's competition here
Fidelity Nasdaq Composite Index ETF (NASDAQ: ONEQ)
JAGLX vs ONEQ Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, ONEQ has a market cap of 11.2B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while ONEQ trades at $104.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas ONEQ's P/E ratio is 30.73. In terms of profitability, JAGLX's ROE is N/A, compared to ONEQ's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to ONEQ. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check ONEQ's competition here
Fidelity Enhanced International ETF (AMEX: FENI)
JAGLX vs FENI Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, FENI has a market cap of 11B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while FENI trades at $41.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas FENI's P/E ratio is 17.59. In terms of profitability, JAGLX's ROE is N/A, compared to FENI's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to FENI. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check FENI's competition here
iShares Global Infrastructure ETF (NASDAQ: IGF)
JAGLX vs IGF Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, IGF has a market cap of 10.5B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while IGF trades at $65.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas IGF's P/E ratio is 21.68. In terms of profitability, JAGLX's ROE is N/A, compared to IGF's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to IGF. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check IGF's competition here
Invesco S&P 500 Top 50 ETF (AMEX: XLG)
JAGLX vs XLG Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, XLG has a market cap of 10.5B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while XLG trades at $63.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas XLG's P/E ratio is 28.87. In terms of profitability, JAGLX's ROE is N/A, compared to XLG's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to XLG. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check XLG's competition here
ClearBridge Large Cap Growth IS (NASDAQ: LSITX)
JAGLX vs LSITX Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, LSITX has a market cap of 10.4B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while LSITX trades at $78.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas LSITX's P/E ratio is 32.79. In terms of profitability, JAGLX's ROE is N/A, compared to LSITX's ROE of N/A. Regarding short-term risk, JAGLX is more volatile compared to LSITX. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check LSITX's competition here
First Trust Nasdaq Cybersecurity ETF (NASDAQ: CIBR)
JAGLX vs CIBR Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, CIBR has a market cap of 10.2B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while CIBR trades at $94.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas CIBR's P/E ratio is 35.48. In terms of profitability, JAGLX's ROE is N/A, compared to CIBR's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to CIBR. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check CIBR's competition here
Dimensional - Emerging Markets Core Equity 2 ETF (AMEX: DFEM)
JAGLX vs DFEM Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, DFEM has a market cap of 9.9B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while DFEM trades at $41.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas DFEM's P/E ratio is 17.32. In terms of profitability, JAGLX's ROE is N/A, compared to DFEM's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to DFEM. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check DFEM's competition here
Schwab Fundamental Emerging Markets Large Company Index ETF (AMEX: FNDE)
JAGLX vs FNDE Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, FNDE has a market cap of 9.6B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while FNDE trades at $43.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas FNDE's P/E ratio is 13.06. In terms of profitability, JAGLX's ROE is N/A, compared to FNDE's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to FNDE. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check FNDE's competition here
Invesco S&P 500 Revenue ETF (AMEX: RWL)
JAGLX vs RWL Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, RWL has a market cap of 9.4B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while RWL trades at $134.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas RWL's P/E ratio is 20.61. In terms of profitability, JAGLX's ROE is N/A, compared to RWL's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to RWL. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check RWL's competition here
Schwab Fundamental U.S. Small Company Index ETF (AMEX: FNDA)
JAGLX vs FNDA Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, FNDA has a market cap of 9.3B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while FNDA trades at $37.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas FNDA's P/E ratio is 20.05. In terms of profitability, JAGLX's ROE is N/A, compared to FNDA's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to FNDA. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check FNDA's competition here
Xtrackers MSCI EAFE Hedged Equity ETF (AMEX: DBEF)
JAGLX vs DBEF Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, DBEF has a market cap of 9.2B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while DBEF trades at $55.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas DBEF's P/E ratio is 19.59. In terms of profitability, JAGLX's ROE is N/A, compared to DBEF's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to DBEF. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check DBEF's competition here
iShares Global Tech ETF (AMEX: IXN)
JAGLX vs IXN Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, IXN has a market cap of 8.8B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while IXN trades at $142.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas IXN's P/E ratio is 32.74. In terms of profitability, JAGLX's ROE is N/A, compared to IXN's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to IXN. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check IXN's competition here
VictoryShares Free Cash Flow ETF (NASDAQ: VFLO)
JAGLX vs VFLO Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, VFLO has a market cap of 8.6B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while VFLO trades at $55.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas VFLO's P/E ratio is 22.66. In terms of profitability, JAGLX's ROE is N/A, compared to VFLO's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to VFLO. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check VFLO's competition here
iShares MSCI World ETF (AMEX: URTH)
JAGLX vs URTH Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, URTH has a market cap of 8.2B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while URTH trades at $209.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas URTH's P/E ratio is 24.93. In terms of profitability, JAGLX's ROE is N/A, compared to URTH's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to URTH. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check URTH's competition here
American Funds Global Growth Portfolio Class F-1 (NASDAQ: PGGFX)
JAGLX vs PGGFX Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, PGGFX has a market cap of 8.2B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while PGGFX trades at $29.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas PGGFX's P/E ratio is 26.49. In terms of profitability, JAGLX's ROE is N/A, compared to PGGFX's ROE of N/A. Regarding short-term risk, JAGLX is more volatile compared to PGGFX. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check PGGFX's competition here
Invesco S&P MidCap Momentum ETF (AMEX: XMMO)
JAGLX vs XMMO Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, XMMO has a market cap of 7.9B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while XMMO trades at $154.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas XMMO's P/E ratio is 28.59. In terms of profitability, JAGLX's ROE is N/A, compared to XMMO's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to XMMO. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check XMMO's competition here
Vanguard Global Equity Fund (NASDAQ: VHGEX)
JAGLX vs VHGEX Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, VHGEX has a market cap of 7.7B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while VHGEX trades at $42.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas VHGEX's P/E ratio is 23.90. In terms of profitability, JAGLX's ROE is N/A, compared to VHGEX's ROE of N/A. Regarding short-term risk, JAGLX is more volatile compared to VHGEX. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check VHGEX's competition here
DFA Global Real Estate Securities Port (NASDAQ: DFGEX)
JAGLX vs DFGEX Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, DFGEX has a market cap of 7.4B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while DFGEX trades at $11.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas DFGEX's P/E ratio is N/A. In terms of profitability, JAGLX's ROE is N/A, compared to DFGEX's ROE of N/A. Regarding short-term risk, JAGLX is more volatile compared to DFGEX. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check DFGEX's competition here
iShares ESG Aware MSCI EM ETF (NASDAQ: ESGE)
JAGLX vs ESGE Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, ESGE has a market cap of 7.4B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while ESGE trades at $55.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas ESGE's P/E ratio is 18.73. In terms of profitability, JAGLX's ROE is N/A, compared to ESGE's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to ESGE. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check ESGE's competition here
WisdomTree Japan Hedged Equity Fund (AMEX: DXJ)
JAGLX vs DXJ Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, DXJ has a market cap of 7.3B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while DXJ trades at $179.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas DXJ's P/E ratio is 18.15. In terms of profitability, JAGLX's ROE is N/A, compared to DXJ's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to DXJ. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check DXJ's competition here
JPMorgan Global Select Equity ETF (NASDAQ: JGLO)
JAGLX vs JGLO Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, JGLO has a market cap of 7.1B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while JGLO trades at $73.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas JGLO's P/E ratio is 24.89. In terms of profitability, JAGLX's ROE is N/A, compared to JGLO's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to JGLO. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check JGLO's competition here
Invesco S&P 500 Low Volatility ETF (AMEX: SPLV)
JAGLX vs SPLV Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, SPLV has a market cap of 6.9B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while SPLV trades at $74.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas SPLV's P/E ratio is 21.12. In terms of profitability, JAGLX's ROE is N/A, compared to SPLV's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to SPLV. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check SPLV's competition here
Vanguard S&P 500 Value ETF (AMEX: VOOV)
JAGLX vs VOOV Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, VOOV has a market cap of 6.8B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while VOOV trades at $228.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas VOOV's P/E ratio is 23.88. In terms of profitability, JAGLX's ROE is N/A, compared to VOOV's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to VOOV. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check VOOV's competition here
Capital Group International Focus Equity ETF (AMEX: CGXU)
JAGLX vs CGXU Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, CGXU has a market cap of 6.5B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while CGXU trades at $35.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas CGXU's P/E ratio is 19.32. In terms of profitability, JAGLX's ROE is N/A, compared to CGXU's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to CGXU. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check CGXU's competition here
T. Rowe Price Global Technology Fund (NASDAQ: PRGTX)
JAGLX vs PRGTX Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, PRGTX has a market cap of 6.5B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while PRGTX trades at $35.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas PRGTX's P/E ratio is 48.05. In terms of profitability, JAGLX's ROE is N/A, compared to PRGTX's ROE of +0.14%. Regarding short-term risk, JAGLX is less volatile compared to PRGTX. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check PRGTX's competition here
Vanguard S&P Small-Cap 600 ETF (AMEX: VIOO)
JAGLX vs VIOO Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, VIOO has a market cap of 6.4B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while VIOO trades at $134.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas VIOO's P/E ratio is 19.18. In terms of profitability, JAGLX's ROE is N/A, compared to VIOO's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to VIOO. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check VIOO's competition here
Vanguard Russell 3000 ETF (NASDAQ: VTHR)
JAGLX vs VTHR Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, VTHR has a market cap of 6.3B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while VTHR trades at $340.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas VTHR's P/E ratio is 26.94. In terms of profitability, JAGLX's ROE is N/A, compared to VTHR's ROE of +0.00%. Regarding short-term risk, JAGLX is more volatile compared to VTHR. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check VTHR's competition here
Janus Henderson Global Life Sciences Fund Class S (NASDAQ: JFNSX)
JAGLX vs JFNSX Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, JFNSX has a market cap of 6.1B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while JFNSX trades at $86.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas JFNSX's P/E ratio is N/A. In terms of profitability, JAGLX's ROE is N/A, compared to JFNSX's ROE of N/A. Regarding short-term risk, JAGLX is less volatile compared to JFNSX. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check JFNSX's competition here
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX)
JAGLX vs JFNCX Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, JFNCX has a market cap of 6.1B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while JFNCX trades at $75.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas JFNCX's P/E ratio is N/A. In terms of profitability, JAGLX's ROE is N/A, compared to JFNCX's ROE of N/A. Regarding short-term risk, JAGLX is less volatile compared to JFNCX. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check JFNCX's competition here
Janus Henderson Global Life Sciences Fund Class N Shares (NASDAQ: JFNNX)
JAGLX vs JFNNX Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, JFNNX has a market cap of 6.1B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while JFNNX trades at $91.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas JFNNX's P/E ratio is N/A. In terms of profitability, JAGLX's ROE is N/A, compared to JFNNX's ROE of N/A. Regarding short-term risk, JAGLX is more volatile compared to JFNNX. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check JFNNX's competition here
Janus Henderson Global Life Sciences Fund (NASDAQ: JFNIX)
JAGLX vs JFNIX Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, JFNIX has a market cap of 6.1B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while JFNIX trades at $91.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas JFNIX's P/E ratio is N/A. In terms of profitability, JAGLX's ROE is N/A, compared to JFNIX's ROE of N/A. Regarding short-term risk, JAGLX is similarly volatile compared to JFNIX. This indicates similar risk in terms of short-term price fluctuations for JAGLX.Check JFNIX's competition here
Janus Henderson Global Life Sciences Fund (NASDAQ: JNGLX)
JAGLX vs JNGLX Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, JNGLX has a market cap of 6.1B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while JNGLX trades at $91.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas JNGLX's P/E ratio is N/A. In terms of profitability, JAGLX's ROE is N/A, compared to JNGLX's ROE of N/A. Regarding short-term risk, JAGLX is more volatile compared to JNGLX. This indicates higher risk in terms of short-term price fluctuations for JAGLX.Check JNGLX's competition here
Columbia Global Technology Growth Fund Institutional 2 Class (NASDAQ: CTHRX)
JAGLX vs CTHRX Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, CTHRX has a market cap of 6B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while CTHRX trades at $143.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas CTHRX's P/E ratio is 36.72. In terms of profitability, JAGLX's ROE is N/A, compared to CTHRX's ROE of N/A. Regarding short-term risk, JAGLX is less volatile compared to CTHRX. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check CTHRX's competition here
Columbia Global Technology Growth Fund (NASDAQ: CMTFX)
JAGLX vs CMTFX Comparison September 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6.1B. In comparison, CMTFX has a market cap of 6B. Regarding current trading prices, JAGLX is priced at $90.74 on the NASDAQ, while CMTFX trades at $139.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas CMTFX's P/E ratio is 36.71. In terms of profitability, JAGLX's ROE is N/A, compared to CMTFX's ROE of N/A. Regarding short-term risk, JAGLX is less volatile compared to CMTFX. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check CMTFX's competition here